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Previously, we reported the expression of chimeric
lipopolysaccharides (LPS) in Escherichia coli strain
JM109 (a K-12 strain) transformed with plasmids con-
taining Haemophilus influenzae lipooligosaccharide
synthesis genes (lsg) (Abu Kwaik, Y., McLaughlin, R. E.,
Apicella, M. A., and Spinola, S. M. (1991) Mol. Microbiol.
5, 2475–2480). In this current study, we have analyzed
the O-deacylated LPS and free oligosaccharides from
three transformants (designated pGEMLOS-4, pGEM-
LOS-5, and pGEMLOS-7) by matrix-assisted laser des-
orption ionization, electrospray ionization, and tandem
mass spectrometry techniques, along with composition
and linkage analyses. These data show that the chimeric
LPS consist of the complete E. coli LPS core structure
glycosylated on the 7-position of the non-reducing ter-
minal branch heptose with oligosaccharides from H. in-
fluenzae. In pGEMLOS-7, the disaccharide Gal13
3GlcNAc13 is added, and in pGEMLOS-5, the structure
is extended to Gal134GlcNAc133Gal133GlcNAc13.
PGEMLOS-5 LPS reacts positively with monoclonal an-
tibody 3F11, an antibody that recognizes the terminal
disaccharide of lacto-N-neotetraose. In pGEMLOS-4
LPS, the 3F11 epitope is apparently blocked by glycosy-
lation on the 6-position of the terminal Gal with either
Gal or GlcNAc. The biosynthesis of these chimeric LPS
was found to be dependent on a functional wecA (for-
merly rfe) gene in E. coli. By using this carbohydrate
expression system, we have been able to examine the
functions of the lsg genes independent of the effects of
other endogenous Haemophilus genes and expressed
proteins.
Capsular strains of Haemophilus influenzae type b (Hib)1 are
responsible for various invasive and bacteremic infections in
humans, including meningitis and pneumonia. The surface
lipooligosaccharides (LOS) of Hib are known to be important
factors in microbial virulence and pathogenesis (1–3). Struc-
tural studies of Hib LOS from wild-type (4, 5) and mutant
strains (6–8) have shown that the LOS contains a conserved
heptose trisaccharide core that can be extended with additional
sugars on each heptose. However, efforts to correlate defined
LOS structures with specific biological functions have been
hindered by the high degree of microheterogeneity and anti-
genic variability of Hib LOS. Additionally, some Hib LOS
epitopes phase vary at high frequencies due to slip-strand
mispairing (9), adding a further level of structural complexity
to wild-type Hib LOS populations.
To facilitate the elucidation of LOS biosynthesis and to de-
termine the relationship of LOS structures to the biology and
pathophysiology of Haemophilus infections, our laboratory has
cloned a gene cluster from Hib strain A2 containing LOS syn-
thesis genes (lsg) (10). The lsg loci are contained within a 7.4-kb
DNA fragment, consisting of seven complete open reading
frames (ORFs) (11). This region is one of several distinct loci
found in the genome sequence of Hib strain Rd (12) that have
been associated with lipopolysaccharide (LPS) biosynthesis
(13). Recently, a series of isogenic mutants of Hib A2 was
generated by transposon mutagenesis of the lsg region using
minitransposon m-Tn3(Cm) (14). Several of the transposon
mutants produced much simpler LOS mixtures than the wild-
type Hib A2 LOS and no longer reacted with one or more of the
monoclonal antibodies (mAbs) recognizing phase-varying or
stable Hib epitopes (14). Structural characterization of the LOS
from two transposon mutants with m-Tn3(Cm) insertions in
lsgD and lsgE has suggested that mutation of these ORFs
prevents the organism from synthesizing many of the higher
molecular weight structures found in wild-type Hib A2 LOS (6).
Strain 281.25, whose mutation was in lsgD, produced only the
basal Hib A2 LOS structures containing glucose (Glc), heptose
(Hep), and 3-deoxy-D-manno-octulosonic acid (Kdo). This strain
did not express the Kdo-related 6E4 epitope characteristic of
Hib LOS, or the 3F11 epitope, which consists of a terminal
N-acetyllactosamine that is common to many strains of Hae-
mophilus and neisserial LOS and has furthermore been impli-
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cated in host mimicry (15). Strain 276.4, whose mutation was
in lsgE, produced similar low molecular weight LOS compo-
nents that failed to react with mAbs 6E4 and 3F11, and one
high molecular weight species that terminated in sialyl-N-
acetyllactosamine. When strain 276.4 was treated with neura-
minidase to remove sialic acid from the sialylated LOS glyco-
form(s), the strain could now be recognized by mAb 3F11. Since
both strains failed to produce any of the high molecular weight
wild-type LOS structures containing galactose (Gal) or to ex-
press the Pk epitope (Gala134Galb134Glc13) associated
with wild-type H. influenzae LOS (4, 15), these studies sug-
gested that lsgD and lsgE are most probably involved in the
transfer of galactose to the LOS.
In a related set of experiments, DNA from the lsg region of
Hib strain A2 was used to construct a genomic library in the
lambda bacteriophage EMBL3 (10). Twenty six phage clones
were prepared that expressed Hib LOS oligosaccharide
epitopes in Escherichia coli strain LE392. The phage transfor-
mant designated EMBLOS-1 produced a chimeric LPS with an
;1.4-kDa oligosaccharide added to the ;4.1-kDa LPS of E. coli
LE392 (10). mAb 6E4, which recognizes a component in the Hib
A2 LOS mixture, also recognized the novel 5.5-kDa component
in the chimeric LPS. Restriction fragments of EMBLOS-1 were
used to make a series of plasmids that modified E. coli strain
JM109 to give clones that produced a proposed chimeric series
of higher mass LPS species (16). The transformants pGEM-
LOS-4, pGEMLOS-5, and pGEMLOS-7 generated modified or
chimeric LPS of ;5.5, 5.1, and 4.5 kDa, respectively (16). All
three apparently modified the ;4.1-kDa LPS species from E.
coli, although only the LPS from pGEMLOS-4 expressed the
6E4 epitope. The LPS from strain pGEMLOS-5 was found to
react positively with mAb 3F11, suggesting the presence of
terminal N-acetyllactosamine.
The epitope recognized by mAb 6E4 is also present in the
LOS of H. influenzae nontypable strain 2019 (17), as well as
the LPS from Salmonella minnesota Re mutant. Binding of
this monoclonal antibody to H. influenzae LOS can be inhib-
ited by Kdo and the Kdo trisaccharide from the Re mutant of
S. minnesota (10). Because the 6E4 epitope has been associ-
ated with the core of Haemophilus LOS, it was originally
proposed that the chimeric structures expressed in E. coli
might arise from the addition of a Haemophilus core struc-
ture to an acceptor residue of the E. coli ;4.1-kDa LPS
species. Recently, a revised structure of the E. coli K-12 core
region was reported that contains a heptose trisaccharide
inner core and a fourth heptose present on the terminus of
the main oligosaccharide branch (18) as shown in Oligosac-
charide 1.
Gala1 Hepa1
2 2
6 7
Hepa13 6Glca13 2Glca13 3Glca13 3Hepa13 3Hepa13 5Kdo3
Oligosaccharide 1
In an effort to establish the chemical structures of the 0.4,
1.0, and 1.4-kDa modifications to the E. coli core and deter-
mine the E. coli acceptor residue, we report here the partial
characterization of the LPS from E. coli strain JM109 and the
three clones pGEMLOS-7, pGEMLOS-5, and pGEMLOS-4
using composition analysis, linkage analysis, and mass
spectrometry.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Vectors—H. influenzae strain A2 was origi-
nally isolated from the spinal fluid of a child with meningitis. Hib A2
was grown on chocolate agar supplemented with IsoVitaleX or brain
heart infusion agar supplemented with 4% Fildes reagent (Difco) at
35 °C in 5% CO2 atmosphere. E. coli strains were routinely cultured at
37 °C using LB agar or broth with appropriate antibiotics (16). Vectors
used in these studies were previously described (10, 16). E. coli K-12
strain 21548 which has a Tn10 insertion in wecA (formerly rfe) was
obtained from Dr. C. Whitfield. This strain was originally described by
Meier-Dieter and co-workers (19).
Transformation of E. coli Strains JM109 and 21548 with Plasmids
Containing Restriction Fragments from the lsg Locus—E. coli strains
JM109 and 21548 were transformed with the plasmid pGEM3Zf1
into which different DNA restriction fragments from the H. influen-
zae strain A2 lsg locus had been ligated (see Table I and Fig. 1) (20).
The plasmid pGEMLOS-4 contained a 7.4-kb BamHI-PstI fragment of
DNA that contained all seven open reading frames (A–G) comprising
the lsg locus (11). The plasmid pGEMLOS-5 contained a 5.5 kb
HindIII-PstI fragment of DNA comprising five open reading frames
(C–G) of the lsg locus. The plasmid pGEMLOS-7 contained a 2.8-kb
SphI-PstI fragment of DNA comprising two open reading frames (F
and G) of the lsg locus. In addition, both strains were transformed
with pGEMG and pGEMF. The plasmid pGEM3zf1 without an insert
was transformed into strain JM109. This strain and the LPS isolated
from it were termed pGEM.
Isolation and SDS-PAGE Analysis of LPS—LPS from E. coli strain
JM109, strain 21548, and the chimeric strains was prepared by the
extraction procedure of Darveau and Hancock (21). The LPS were
separated by SDS-PAGE in resolving gels containing 15% acrylamide
TABLE I
Bacterial strains and vectors
Strain/plasmid Relevant characteristics Ref./source
E. coli
JM109 recA, supE, hsR, D(lac-pro) 48
21548 K-12, thr-1,leuB6 D(gpt-proA06, hisG4,
argE3, thi-1, lacY1, ara-14, galK2, xyl-5,
mtl-1, mgl-51, rpsL31, kdgK51, supE44,
wecA::Tn10–48)
19
H. influenzae
A2 Parental strain 10
Plasmids
pGEM3Zf1 ApR Promega Biotech
pGEMLOS-4 ApR, contains 7.4-kb BamHI-PstI DNA H.
influenzae lsg locus
This study
pGEMLOS-5 ApR, contains 5.5-kb HindIII-PstI DNA H.
influenzae lsg locus
This study
pGEMLOS-7 ApR, contains 2.8-kb SphI-PstI DNA H.
influenzae lsg locus
This study
pGEMG ApR, contains ORF lsgG This study
pGEMF ApR, contains ORF lsgF This study
Chimeric LPS from E. coli4748
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and visualized by silver staining (22). The nomenclature for the various
LPS preparations is as follows: pGEM, pGEMLOS-4, pGEMLOS-5,
pGEMLOS-7, pGEMG, and pGEMF were all isolated from strain
JM109 transformed with plasmids pGEM3zf1, pGEMLOS-4, pGEM-
LOS-5, pGEMLOS-7, pGEMG, and pGEMF, respectively (see Table I).
The LPS preparations isolated from the wecA- strain 21548 trans-
formed with the same set of plasmids were designated pGEMrfe,
pGEMLOS-4rfe, pGEMLOS-5rfe, pGEMLOS-7rfe, pGEMGrfe, and
pGEMFrfe.
O-Deacylation of LPS—A few milligrams of LPS from each sample
were treated with anhydrous hydrazine at 37 °C for 20 min (23) and
then precipitated with cold acetone as described previously (17).
Isolation and Purification of Oligosaccharides—The LPS from
pGEM (31 mg), pGEMLOS-4 (25 mg), pGEMLOS-5 (15 mg), and
pGEMLOS-7 (4.4 mg) was hydrolyzed in 1% acetic acid (2 mg of
LPS/ml) for 2 h at 100 °C. The hydrolysates were centrifuged at
5000 3 g for 20 min at 4 °C and the supernatants removed. The
pellets were washed with 2 ml of H2O and centrifuged again (5000 3
g, 20 min, 4 °C). The supernatants and washings were pooled and
lyophilized to give the oligosaccharide fractions. As a standard, 10 mg
of LPS from Salmonella typhimurium TV119 Ra mutant (Sigma) was
treated in the same fashion.
To prepare desalted oligosaccharide pools for ESI-MS analysis, small
aliquots of the crude oligosaccharide fractions (,2 mg) were chromato-
graphed on two Bio-Select SEC 125–5 HPLC columns (Bio-Rad) con-
nected in series, using 0.05 M pyridinium acetate (pH 5.2) at a flow rate
of 1 ml/min. A refractive index detector (Knauer) was used to monitor
column effluent, and chromatograms were recorded and stored with a
Shimadzu C-R3A Chromatopac integrator.
For large scale separations, the oligosaccharide fractions from pGEM
(10.2 mg), pGEMLOS-4 (9.3 mg), and pGEMLOS-5 (7.0 mg) were dis-
solved in 0.3 ml of 0.05 M pyridinium acetate buffer (pH 5.2) and
centrifuge-filtered through a 0.45-mm Nylon-66 membrane (Microfilter-
fuge tube, Rainin). The pGEM and pGEMLOS-4 samples were applied
to a single Bio-Gel P-4 column (1.6 3 84 cm, ,400 mesh; Bio-Rad), and
the pGEMLOS-5 sample was applied to two Bio-Gel P-4 columns con-
nected in series (1.6 3 79 cm and 1.6 3 76.5 cm). The columns were
equipped with water jackets maintained at 30 °C. Upward elution at a
flow rate of 10 ml/h was achieved with a P-1 peristaltic pump (Amer-
sham Pharmacia Biotech). Effluent was monitored with refractive in-
dex, and fractions were collected at 10-min intervals and evaporated to
dryness in a Speed-Vac concentrator.
Dephosphorylation of Oligosaccharides—Oligosaccharide fractions
were placed in 1.5-ml polypropylene tubes and treated with cold 48%
aqueous HF (Mallinckrodt) to make 5–10 mg/ml solutions. Samples
were kept for 18 h at 4 °C and then aqueous HF was evaporated as
described previously (17). The dephosphorylated samples were then
rechromatographed on two Bio-Select SEC 125–5 HPLC columns
connected in series using 0.05 M pyridinium acetate (pH 5.2) as
described above.
Monosaccharide Composition Analysis—Dephosphorylated oligosac-
charide fractions were dissolved in 400 ml of 2 M trifluoroacetic acid and
heated for 4 h at 100 °C. The hydrolysates were evaporated to dryness
in a Speed-Vac concentrator, redissolved in 20 ml H2O, and dried again.
Hydrolysates were analyzed by high performance anion exchange chro-
matography with pulsed amperometric detection (24) using a Dionex
BioLC system (Dionex, Sunnyvale, CA) with a CarboPac PA1 column as
described previously (17).
Methylation Analysis—Linkage analysis was performed on dephos-
phorylated oligosaccharide fractions using the microscale method (25)
modified for use with powdered NaOH (26). Details of this procedure
have been reported elsewhere (17). Partially methylated alditol ace-
tates were analyzed by gas chromatography/MS in the EI and CI modes
on a VG70SE mass spectrometer as described previously (27).
Liquid Secondary Ion Mass Spectrometry (LSIMS)—LSIMS was per-
formed using a Kratos MS50S mass spectrometer with a cesium ion
source (28). Oligosaccharide samples (in 1 ml of H2O) were added to 1 ml
of glycerol/thioglycerol (1:1) on a stainless steel probe tip. A Cs1 ion
primary beam energy of 10 keV was used, and the secondary sample
ions were accelerated to 8 keV. Scans were taken in the negative ion
mode at 300 s/decade and recorded with a Gould ES-1000 electrostatic
recorder. The spectra were mass calibrated manually with Ultramark
1621 (PCR Research Chemicals, Inc., Gainesville, FL) to an accuracy of
better than 60.2 Da.
Electrospray Ionization-Mass Spectrometry (ESI-MS)—Oligosac-
charides and O-deacylated LPS were analyzed on either a VG Plat-
form mass spectrometer (VG Instruments, Manchester, UK) or a
Sciex API 300 triple quadrupole mass spectrometer with an electro-
spray ion source operating in the negative ion mode. Oligosaccharide
samples were dissolved in H2O, mixed with running solvent (1 ml in
4 ml), and injected via a Rheodyne injector into a stream of H2O/
acetonitrile (1/1, v/v) containing 1% acetic acid, at a flow rate of ;20
ml/min. Mass calibration was carried out with CsI in the negative ion
mode.
In some cases, selected oligosaccharide fractions were analyzed at
higher resolving power (M/DM 5 2000) using a Micromass Autospec
sector-orthogonal time of flight (TOF) instrument with an array detec-
tor (29) operating under ESI conditions in the negative ion mode. In this
case, the solvent system and flow rate were essentially the same as
described above for the quadrupole ESI experiments. A scan speed of 5
s/decade was used for all samples over the m/z range of 500–3000 with
a accelerating voltage of 4 kV and an ESI needle voltage of between 3.5
and 4 kV higher. Mass calibration was carried out with an external
reference consisting of CsI taken under liquid secondary ion mass
spectrometry conditions, followed by a one-point correction of the dou-
bly charged deprotonated molecular ion of the oligosaccharide from the
LPS of S. typhimurium Ra mutant ((M 2 2H)22 exact 5 973.2) in the
negative ion ESI-MS mode.
Matrix-assisted Laser Desorption Ionization (MALDI) Mass Spec-
trometry—O-Deacylated LPS samples were analyzed on a Voyager or
an Elite MALDI-TOF instrument (PE Biosystems, Framingham, MA)
equipped with a nitrogen laser (337 nM). All spectra were recorded in
the negative ion mode using delayed extraction conditions as described
in detail elsewhere (30). Samples were dissolved in H2O (;250 pmol/ml)
and mixed 1:1 with the matrix solution (a saturated solution of 2,5-
dihydroxybenzoic acid in acetone) and allowed to dry at room temper-
ature on a gold-plated MALDI plate. Approximately 100 laser shots
were recorded for each sample, averaged, and then mass calibrated
using an external mass calibrant consisting of renin substrate tetrade-
capeptide, insulin chain B, oxidized, and bovine insulin (all from Sig-
ma). For external calibrations under these conditions, a mass accuracy
of #0.1% was obtained. For comparison purposes, a single point correc-
tion was made to the spectra of the O-deacylated LPS from pGEM using
the expected lipid A fragment ion (average (M 2 H)2 at m/z 952.009),
and then the spectra for the three chimeric strains were recalibrated
using this lipid A fragment ion and an additional ion from pGEM (m/z
2835.7) present in all four samples.
Tandem Mass Spectrometry (MS/MS) Using Quadrupole-TOF—
Dephosphorylated oligosaccharides were analyzed in the positive ion
mode on a PE Sciex (Concorde, Ontario, Canada) QSTAR mass spec-
trometer equipped with a Protana nanospray ion source. The QSTAR
analyzer consists of a high pressure RF-only ion guide followed by a
quadrupole mass filter. A high pressure quadrupole collision cell
follows the first mass filter. The TOF mass analyzer is comprised of
a reflectron with an effective flight path of 2.5 meters. Samples were
dissolved in H2O/acetonitrile (1:1, v/v) containing 1% acetic acid, and
2 ml of each was injected into a Protana nanospray tip. The nanospray
needle voltage was typically 800–1000 V. One sample loading usually
gave an analysis time of 30–40 min, which allowed a conventional
mass spectrum to be obtained prior to the selection of several indi-
vidual ions for CID MS/MS. In MS mode the high resolution capabil-
ity (8,000 FWHM) allowed unambiguous determination of the charge
state for each ion. For CID-MS/MS operation the quadrupole mass
analyzer with a mass window of 1 m/z unit was used to select
precursor ions for fragmentation, which in most cases were doubly
charged (M 1 2H)21. The selected ions were fragmented in a collision
cell with air as the collision gas and analyzed in the orthogonal TOF
operating at an accelerating potential of 20 kV. Fragment ion spectra
were accumulated under computer control for periods of between 10 s
and 1 min. Mass assignments based on external calibration were
generally within 50 ppm of calculated monoisotopic values, whereas
internal calibration gave masses accurate to 65 ppm.
RESULTS
SDS-PAGE Analysis of LPS—We have previously reported
the transformation of E. coli strain JM109 (a K-12 strain that
produces rough LPS (r-LPS) that lack the O side chain) with a
series of plasmids containing overlapping restriction fragments
of DNA from the lsg region of H. influenzae type b strain A2
(16). As diagrammed in Fig. 1, the pGEMLOS-4 clone contains
all of the complete ORFs (lsgA-lsgG) in the lsg region, whereas
pGEMLOS-5 contains lsgC-lsgG, and pGEMLOS-7 contains
lsgF-lsgG. The clones pGEMLOS-4, pGEMLOS-5, and pGEM-
LOS-7 were originally shown by SDS-PAGE to produce modi-
Chimeric LPS from E. coli 4749
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fied LPS structures which added ;1.4, 1.0, and 0.4-kDa moi-
eties, respectively, to the ;4.1-kDa E. coli core (16). In more
recent SDS-PAGE gels, the modified LPS was further resolved
and no longer appears as a dominant single band (Fig. 2, top).
Rather, the LPS appear to consist of several bands whose
estimated sizes differ slightly from those reported originally
(see legend, Fig. 2). When tested against two mAbs that recog-
nize H. influenzae epitopes, pGEMLOS-4 LPS reacted posi-
tively with mAb 6E4 (which recognizes a Kdo-related epitope in
H. influenzae), and pGEMLOS-5 LPS reacted positively with
mAb 3F11 (which recognizes the terminal disaccharide of lacto-
N-neotetraose, Galb134GlcNAcb133Galb134Glc13). The
LPS from pGEMLOS-7, which contains the smallest modifica-
tion, did not react with either antibody. Thus, the antibody
recognition data and LPS size differences suggested that the
lsg region contains a cluster of at least three genetic loci whose
products sequentially modify H. influenzae LOS (16). To con-
firm the chimeric nature of the pGEMLOS-4, pGEMLOS-5, and
pGEMLOS-7 LPS and identify H. influenzae epitopes being
expressed, LPS from these clones and from the parent E. coli
strain transformed with a plasmid lacking an insert (designat-
ed pGEM) were analyzed by various chemical and mass spec-
trometric methods as described below.
In order to define better the molecular mechanisms involved
in the assembly of the chimeric LPS, we cloned the same
plasmids as above plus plasmids containing only ORF lsgG and
lsgF into strain 21548 which contains a Tn10 insertion in wecA
(formerly rfe). The presence of a functional wecA is necessary
for the synthesis of O-polysaccharides containing GlcNAc. The
SDS-PAGE in Fig. 2 (bottom) demonstrates that a functional
wecA is necessary for generation of the chimeric LPSs by the
pGEMLOS-7, -5, and -4 plasmids.
Analysis of O-Deacylated LPS by MALDI-TOF—For initial
screening of LPS molecular weights and heterogeneity by mass
spectrometry, small aliquots of LPS from pGEM, pGEMLOS-4,
pGEMLOS-5, and pGEMLOS-7 were treated with anhydrous
hydrazine to remove O-linked fatty acids from the lipid A
moiety. The negative ion MALDI-TOF spectra of these O-deac-
ylated LPS samples (30) are shown in Fig. 3. Although all of the
samples are clearly quite heterogeneous, the MALDI-TOF
spectra easily show how progressively larger molecular weight
LPS are made by the transformants as a function of H. influ-
enzae ORFs present. The pGEM O-deacylated LPS sample
FIG. 2. Top, SDS-PAGE gel of the LPS from E. coli strain JM109
(pGEM) and the three chimeric strains. Lanes are as follows: A, pGEM;
B, pGEMLOS-7; C, pGEMLOS-5; and D, pGEMLOS-4. Molecular
weight markers indicated are the calculated masses of the LOS from N.
gonorrhoeae strain PID2 (47). The apparent sizes of the most abundant
moieties (labeled with arrows) added to the main E. coli LPS band at
;3.9 kDa, i.e. ;0.3, 0.5, and 0.6 kDa for pGEMLOS-7, -5, and -4,
respectively, appear smaller than those originally suggested by SDS-
PAGE (16) but closer to masses determined by mass spectrometry.
Bottom, SDS-PAGE gel of the LPS produced when the lsg genes are
transformed into E. coli strain 21548, a wecA2 mutant. Lanes are as
follows: E, PID2 from N. gonorrhoeae; F, pGEMrfe; G, pGEMGrfe; H,
pGEMFrfe; I, pGEMLOS-7rfe; J, pGEMLOS-5rfe; K, pGEMLOS-4rfe.
FIG. 3. Negative ion MALDI-TOF spectra of the O-deacylated
LPS from pGEM (A), pGEMLOS-7 (B), pGEMLOS-5 (C), and
pGEMLOS-4 (D) recorded under delayed extraction conditions
(30).
FIG. 1. The lsg region of H. influenzae DNA. A, diagram of the
eight ORFs. B, locations of m-Tn3(Cm) insertion sites (6). C, restriction
maps of the EMBLOS-1 subclones that modified the E. coli JM109 LPS
(adapted from Ref. 16).
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contains several species in the range of 2738–3172 Da,2 repre-
senting the major E. coli core structures. When fit to proposed
compositions,3 the observed species were found to exhibit het-
erogeneity in heptose (Hep), hexose (Hex), 3-deoxy-D-manno-
octulosonic acid (Kdo), phosphate, and phosphoethanolamine
(PEA) (Table II). Specifically, two main core types were ob-
served containing either 3 Hex and 3 Hep (with 2 or 3 Kdos) or
4 Hex and 4 Hep (with 2 Kdos), with variable amounts of
phosphate and PEA in both. The pGEMLOS-7 O-deacylated
LPS mixture contained many of these same species, in addition
to two major new species at m/z 3334.5 and 3456.8 (Fig. 3). The
m/z 3334.5 species apparently arises from the addition of Hex
and N-acetylhexosamine (HexNAc) to the pGEM core structure
containing 4 Hex, 4 Hep, 2 Kdo, 2 phosphates, and 1 O-deac-
ylated diphosphorylated lipid A (O-DPLA) moiety. A further
addition of 1 PEA moiety gives the m/z 3456.8 species. These
data suggest that the transformation producing pGEMLOS-7
results in the addition of a Hex-HexNAc moiety to the E. coli
LPS. Likewise, the main species in the pGEMLOS-5 O-deacyl-
ated LPS (m/z 3700.6 and 3823.6) were found to arise from the
addition of 2 Hex plus 2 HexNAc to the pGEM core structure
containing 4 Hex, 4 Hep, 2 Kdo, 2 phosphates, 1 O-DPLA, and
0 or 1 PEA. These structures are also found in the pGEMLOS-4
O-deacylated LPS, in addition to new species arising from the
further addition of either another Hex (m/z 4083.2 and 4206.4)
or HexNAc (m/z 4124.5 and 4246.8) to, in this case, the pGEM
core structure containing 4 Hex, 4 Hep, 3 Kdo, 2 phosphates, 1
O-DPLA, and 0 or 1 PEA. Of the chimeric LPS structures, only
these high molecular weight pGEMLOS-4 components con-
tained the third Kdo moiety.
Analysis of Oligosaccharides by ESI-MS and LSIMS—The
LPS from pGEM, pGEMLOS-4, pGEMLOS-5, and pGEM-
LOS-7 were subjected to mild acid hydrolysis to liberate free
oligosaccharides. Initially, small aliquots of the oligosaccharide
fractions were desalted by size exclusion HPLC and analyzed
as mixtures by negative ion ESI-MS (Fig. 4). The ESI-MS
spectra contained predominantly doubly charged ions (M 2
2 Ions measured by LSIMS and ESI-MS (unless otherwise noted) are
monoisotopic masses of the 12C-containing component, and ions ob-
served by MALDI-TOF are average masses.
3 Residue mass values (monoisotopic mass, average mass) for LOS
and LPS structural moieties are as follows: Hex (162.053, 162.142), Hep
(192.063, 192.169), HexNAc (203.079, 203.195), Kdo (220.058, 220.179),
NeuAc (291.095, 291.258), phosphate (79.966, 79.980), PEA (123.008,
123.048), and diphosphorylated O-deacylated lipid A (934.457,
934.994).
FIG. 4. Negative ion ESI-MS of the oligosaccharide pools from
the LPS of pGEM (A), pGEMLOS-7 (B), pGEMLOS-5 (C), and
pGEMLOS-4 (D). Peaks marked with asterisks are anhydro species.
TABLE II
Molecular weights and proposed compositions of the O-deacylated LPS from pGEM, pGEMLOS-7, pGEMLOS-5, and pGEMLOS-4
Relative ion abundances are given in parentheses. P indicates phosphate.
pGEM pGEMLOS-7 pGEMLOS-5 pGEMLOS-4 Calc. Mr
Proposed compositions
HexNAc Hex Hep P PEA Kdo O-DPLA
Chimeric structures
4247.8 (40) 4247.6 3 6 4 2 1 3 1
4207.4 (26) 4206.6 2 7 4 2 1 3 1
4125.5 (46) 4124.6 3 6 4 2 3 1
4084.2 (27) 4083.6 2 7 4 2 3 1
3947.4 (38) 3947.3 2 6 4 2 2 2 1
3904.4 (25) 3904.3 2 6 4 3 1 2 1
3824.6 (100) 3824.4 (40) 3824.3 2 6 4 2 1 2 1
3701.6 (90) 3701.3 (100) 3701.2 2 6 4 2 2 1
3603.8 (31) 3603.6 (26) 3604.1 2 6 4 2 1 1 1
3457.8 (41) 3458.9 1 5 4 2 1 2 1
3335.5 (43) 3335.9 1 5 4 2 2 1
Core structures
3172.7 (43) 3173.6 4 4 3 1 2 1
3093.2 (97) 3093.5 (74) 3094.0 (42) 3093.6 4 4 2 1 2 1
3050.4 (67) 3050.6 4 4 3 2 1
2970.1 (100) 2970.6 (100) 2970.8 (68) 2970.6 4 4 2 2 1
2958.5 (90) 2958.8 (76) 2959.5 (87) 2960.2 (60) 2959.5 3 3 2 1 3 1
2941.9 (56) 2942.3 3 3 3 2 2 1
2836.7 (87) 2836.7 (68) 2836.7 (90) 2836.7 (99) 2836.4 3 3 2 3 1
2819.2 (70) 2818.8 (49) 2819.3 3 3 3 1 2 1
2738.4 (40) 2738.8 (41) 2739.0 (62) 2738.7 (54) 2739.3 3 3 2 1 2 1
2616.5 (39) 2616.2 (39) 2616.2 3 3 2 2 1
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2H)22. In general, the data were consistent with results from
the MALDI-TOF analysis of O-deacylated LPS (Fig. 3). The
pGEM sample was found to contain seven major oligosaccha-
rides and several minor species, ranging in molecular weight
from 1459.3 to 2016.7. As shown in Table III, proposed compo-
sitions were determined for the various species which indicated
that the structures consisted of two main core types as follows:
one containing 3 Hex, 3 Hep, and 1 Kdo, and another contain-
ing 4 Hex, 4 Hep, and 1 Kdo. Variability in the number of
phosphate and PEA groups was responsible for the large num-
ber of species present in the mixture.
The pGEMLOS-4, pGEMLOS-5, and pGEMLOS-7 samples
contained many of the species found in the pGEM sample, in
addition to larger molecular weight oligosaccharides (Table
III). New LPS glycoforms of Mr 2177.7 and 2302.5 were ob-
served in the pGEMLOS-7 sample, consistent with the addition
of a single Hex and HexNAc residue to the pGEM core struc-
ture containing 4 Hex, 4 Hep, 1 Kdo, 2 phosphates, and 0 or 1
PEA. The high molecular weight components of the pGEM-
LOS-5 sample (Mr 2543.9 and 2666.5) suggested the further
addition of yet another Hex-HexNAc unit, and the pGEMLOS-4
sample contained even higher molecular weight materials
(ranging from Mr 2706.1 to 2870.0) consistent with the addition
of one more Hex or HexNAc moiety.
To aid in the determination of proposed compositions for
these species, oligosaccharides from the pGEM, pGEMLOS-4,
pGEMLOS-5, and pGEMLOS-7 samples were separated by
size exclusion chromatography, and fractions were analyzed
by LSIMS and/or ESI-MS. Selected fractions representing the
two major pGEM core types and the various chimeric struc-
tures were then pooled, dephosphorylated with aqueous HF,
rechromatographed on size exclusion HPLC, and analyzed
again by negative ion LSIMS or ESI-MS. Proposed composi-
tions for the molecular ions observed after HF treatment are
listed in Table IV, and Fig. 5 shows examples of ESI spectra
for four of the fractions. Upon removal of phosphate and PEA
moieties, the major high mass species present in the pGEM-
LOS-7 sample is an oligosaccharide of average Mr 2020.3 (1
HexNAc, 5 Hex, 4 Hep, and 1 Kdo). The pGEMLOS-5 sample
contains an oligosaccharide with an average Mr of 2386.3,
resulting from the further addition of 1 Hex and 1 HexNAc to
the pGEMLOS-7 LPS (2 HexNAc, 6 Hex, 4 Hep, and 1 Kdo).
This species is also present in the pGEMLOS-4 sample, in
addition to higher molecular weight structures containing an
additional Hex (Mr average 5 2548.4) or HexNAc (Mr aver-
age 5 2589.5).
Monosaccharide Composition and Linkage Analyses—Mass
spectrometric analyses of the free oligosaccharides from pGEM,
pGEMLOS-4, pGEMLOS-5, and pGEMLOS-7 indicated that
the different chimeric structures arise from additions of stoi-
chiometric amounts of hexose and HexNAc residues to a vari-
ably phosphorylated pGEM core structure containing 4 Hex, 4
Hep, and 1 Kdo. No chimeric structures were observed to con-
tain the 3 Hex, 3 Hep, and 1 Kdo core. For comparison pur-
poses, dephosphorylated oligosaccharide fractions containing
the two pGEM core types and the main chimeric structures
from pGEMLOS-4, pGEMLOS-5, and pGEMLOS-7 were hy-
drolyzed in 2 N trifluoroacetic acid to determine their monosac-
charide compositions and therefore the identities of the Hex
and HexNAc residues. When analyzed by high pH anion ex-
change chromatography with pulsed amperometric detection,
the pGEM hydrolysates were found to contain only galactose,
glucose, and L-glycero-D-manno-heptose (Table V). (The Kdo
residue is not recovered under these hydrolysis conditions.)
The two core types were identified as GalGlc2Hep3 and
GalGlc3Hep4. The pGEMLOS-7 sample contained GlcNH2
Gal2Glc3Hep4, suggesting that the larger pGEM core was being
modified by the addition of one Gal and one N-acetylglu-
cosamine (GlcNAc) residue. Likewise, the composition of the
pGEMLOS-5 sample suggested that the larger pGEM core was
being further glycosylated with only Gal and GlcNAc residues.
Fraction 2 from pGEMLOS-4, which contained the same spe-
cies as pGEMLOS-5, gave similar results, and fraction 1 from
pGEMLOS-4, which contains three main species (see Table IV),
contained slightly more GlcNH2.
Aliquots of the same six dephosphorylated oligosaccharide
fractions used for monosaccharide composition analysis were
taken for methylation analysis to establish sugar linkage posi-
tions. The partially methylated alditol acetates observed by gas
chromatography/MS are listed in Table VI. Again, by compar-
TABLE III
Molecular weights and proposed compositions of the oligosaccharides from pGEM, pGEMLOS-7, pGEMLOS-5, and pGEMLOS-4
Relative ion abundances (given in parentheses) represent the sum of the monoisotopic molecular ion and anhydro peaks for a given species (see
Fig. 4). P indicates phosphate.
pGEM pGEMLOS-7 pGEMLOS-5 pGEMLOS-4 CalculatedMr
Proposed compositions
HexNAc Hex Hep P PEA Kdo
Chimeric structures
2870.0 (12) 2870.8 3 6 4 2 1 1
2828.6 (10) 2827.8 3 6 4 3 1
2747.8 (13) 2747.8 3 6 4 2 1
2706.1 (12) 2706.8 2 7 4 2 1
2666.5 (20) 2666.7 (13) 2667.7 2 6 4 2 1 1
2543.9 (58) 2544.0 (31) 2544.7 2 6 4 2 1
2302.5 (30) 2302.6 1 5 4 2 1 1
2177.7 (45) 2179.6 1 5 4 2 1
Core structures
2058.6 (23) 2060.5 4 4 2 2 1
2016.7 (13) 2017.4 4 4 3 1 1
1937.2 (50) 1937.1 (52) 1937.1 (15) 1937.5 4 4 2 1 1
1893.5 (51) 1894.4 4 4 3 1
1814.0 (100) 1814.0 (54) 1814.0 (19) 1814.4 4 4 2 1
1743.9 (19) 1745.4 4 3 2 1 1
1705.8 (24) 1705.9 (11) 1705.8 (14) 1706.4 3 3 2 2 1
1622.4 (15) 1622.5 (14) 1622.4 4 3 2 1
1582.9 (49) 1582.8 (100) 1582.8 (53) 1582.9 (68) 1583.4 3 3 2 1 1
1539.2 (51) 1539.3 (16) 1539.3 (19) 1540.3 3 3 3 1
1459.3 (78) 1459.9 (50) 1459.9 (100) 1459.8 (100) 1460.3 3 3 2 1
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ing the two pGEM core types, it is relatively straightforward to
see that the second terminal heptose of the larger pGEM core is
converted to a 1,7-linked heptose in all of the chimeric struc-
tures and thus must represent the linkage site for the novel
glycosylation. Since no chimeric structures were observed with
the Hep3 core, it is most likely that the non-reducing terminal
heptose recently identified on the oligosaccharide branch in the
K-12 core structure (18) is the modified terminal heptose. Ad-
ditionally, no new tri-linked saccharides were obtained from
the chimeric oligosaccharides, suggesting that the sugars were
most likely all added in a straight chain.
Sequencing of Chimeric Oligosaccharides by MS/MS—To
confirm the identity of the linkage site between the E. coli LPS
core and the novel oligosaccharide moieties, and to determine
the sequences of the added sugars, the dephosphorylated oli-
gosaccharides were subjected to MS/MS analysis. For these
experiments, samples were run in the positive ion mode and
doubly charged molecular ions, (M 1 2H)21, were selected for
collision-induced dissociation (CID). The resulting MS/MS
spectra of the pGEM core oligosaccharide (Mr 1654.5) and the
pGEMLOS-5 chimeric structure (Mr 2384.8) are shown in Fig.
6. Various reducing terminal (Y-type) and non-reducing termi-
nal (B-type) sequence ions are present in the spectra. For the
pGEM oligosaccharide (Fig. 6A), the Y ion series including the
Y6a9 (m/z 732.2 (21)), Y5a9 (m/z 651.2 (21)), and Y4a9 (m/z
1139.3) fragment ions and the corresponding B ion series in-
cluding the B3a9 (m/z 517.2), B4a9 (m/z 841.3), B5 (m/z 1225.4),
and B6 (m/z 1417.4) fragment ions support the published
structure with the fourth heptose on the non-reducing termi-
nus of the largest oligosaccharide branch. In addition to these
sequence ions, several ions present in the spectrum apparently
arise from internal cleavages, which can occur under high
energy CID conditions. In the spectrum of the pGEMLOS-5
oligosaccharide (Fig. 6B), two similar Y and B type ion series
clearly define the sequence and linkage site of the added tet-
rasaccharide. Intense B ions at m/z 366.1 (B2a9) and 731.3
(B4a9) arise from the sequential cleavage of two Hex-HexNAc
moieties. These losses are also represented by the correspond-
ing Y9a9 (m/z 2020.6) and Y7a9 (m/z 1655.5) fragment ions.
Fragment ions at m/z 923.3 (B5a9) and m/z 1463.4 (Y6a9) con-
firm that the Hex-HexNAc-Hex-HexNAc moiety is linked to a
heptose, and additional cleavages further along the large oli-
gosaccharide branch (the B6a9, B7a9, and Y5a9 ions) confirm that
the novel tetrasaccharide is attached to the largest branch of
the pGEM core structure, as indicated in Fig. 6B.
In the MS/MS spectra of the chimeric oligosaccharides from
pGEMLOS-7 and pGEMLOS-4, intense B ions also clearly de-
fined the structures of the added sugar moieties. In the pGEM-
LOS-7 oligosaccharide (Mr 2019.7), a B ion at m/z 366.1 cor-
responds to a single Hex-HexNAc disaccharide moiety. The
pGEMLOS-4 oligosaccharide of Mr 2587.9 (HexNAc3
Hex6Hep4Kdo) lost a HexNAc-Hex-HexNAc fragment (m/z
569.2) and a HexNAc-Hex-HexNAc-Hex-HexNAc fragment
(m/z 934.3), whereas the pGEMLOS-4 oligosaccharide of Mr
2546.8 (HexNAc2Hex7Hep4Kdo) lost a Hex-Hex-HexNAc (m/z
528.2) and a Hex-Hex-HexNAc-Hex-HexNAc (m/z 893.3) frag-
ment. In addition to those B-type ions, the latter spectrum also
contained large ions at m/z 366.1 and 731.3, which apparently
arise as internal fragments in that case.
Assuming that the oligosaccharides are built up sequen-
tially, i.e. from pGEMLOS-7 to pGEMLOS-5 to pGEMLOS-4,
the MS/MS data, in combination with our methylation analysis
results, allows the partial structures of the chimeric oligosac-
charides to be deduced as shown in Fig. 7.
DISCUSSION
In this study, we have provided structural data to support
our original hypothesis that E. coli K-12 transformed with
plasmids containing portions of an eight gene segment from H.
TABLE IV
Molecular weights and proposed compositions of the dephosphorylated oligosaccharides from pGEM, pGEMLOS-7, pGEMLOS-5, and
pGEMLOS-4
Fraction Observed Mr(average)
Calculated Mr Proposed compositions
Average Exact HexNAc Hex Hep Kdo
pGEM (fraction 2) 1300.8 1301.1 1300.4 3 3 1
pGEM (fraction 1) 1655.3 1655.4 1654.5 4 4 1
pGEMLOS-7 2020.3 2020.8 2019.7 1 5 4 1
pGEMLOS-5 2386.3 2386.1 2384.8 2 6 4 1
pGEMLOS-4 (fraction 2) 2386.3 2386.1 2384.8 2 6 4 1
pGEMLOS-4 (fraction 1) 2386.1 2386.1 2384.8 2 6 4 1
2548.4 2548.2 2546.8 2 7 4 1
2589.5 2589.3 2587.9 3 6 4 1
FIG. 5. Negative ion ESI-MS of the dephosphorylated oligosac-
charide fractions used for composition and methylation analy-
ses: pGEM fraction 1 (A), pGEMLOS-7 (B), pGEMLOS-5 (C), and
pGEMLOS-4 fraction 1 (D). Ions below m/z 1400 in spectra B–D are
doubly charged ions arising from incompletely dephosphorylated
glycoforms.
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influenzae involved in LOS biosynthesis makes chimeric LPS
(10). Moreover, we have shown that the chimeric LPS are
segregated hybrid-type structures, where the E. coli r-LPS core
structure is first synthesized and then serves as a scaffold for
H. influenzae LOS biosynthesis enzymes to add a second inde-
pendent set of sugars not found in the parent E. coli strain.
Thus, the biosynthetic pathways appear to be sequential (seg-
regated) and not intermixed.
One of the more interesting outcomes of the chemical anal-
ysis of these chimeric LPS species is the role of the terminal
branch heptose in the E. coli r-LPS as the acceptor for oligo-
saccharide elongation. When we began this work, the pub-
lished structure for the complete E. coli K-12 core did not
contain a second terminal heptose but rather had this fourth
heptose as part of the inner core region (31). The oligosac-
charide branch was believed to terminate in glucose, which
was proposed to be the acceptor site for O-antigen and other
substituents (31). From our initial observations, it was ap-
parent that only E. coli r-LPS structures containing this
fourth heptose (i.e. complete core structures) underwent elon-
gation in the plasmid-transformed chimeric strains. When a
correction to the complete K-12 structure was published that
placed the fourth heptose on the non-reducing terminus of
the oligosaccharide branch (18), as opposed to the inner core,
our findings became easier to interpret. The revised core
structure is consistent with the linkage analysis data ob-
tained in our study and also provides a more accessible and
logical acceptor site for chain elongation.
In the chimeric structures, GlcNAc is the first sugar added
to the 7-position of this heptose. We found that for this crucial
first step in the elongation sequence to occur, E. coli must
have a functional wecA gene. WecA is involved in O-antigen
biosynthesis in E. coli. There are several different pathways
involved in O-antigen biosynthesis. In the biosynthesis path-
ways utilized by homopolymeric O-antigens in E. coli 08 and
09, the polymer is elongated on the non-reducing terminus of
a GlcNAc-pyrophosporyl-undecaprenol carrier lipid (19, 32,
33). This pathway is initiated by WecA that transfers UDP-
GlcNAc to the isoprenoid carrier. The GlcNAc subsequently
accepts sequentially transferred monosaccharides one unit at
a time. The GlcNAc is used to initiate the polymer and
becomes part of the repeating O-antigen unit in E. coli 018,
075, and 0111 (32). In the case of E. coli K-12, it was recently
shown that when mutations causing the rough phenotype are
complemented, the complemented strains can also produce
an O-antigen which has GlcNAc at the reducing terminus of
the repeat unit (34). The inability to form an H. influenzae–E.
coli LOS chimeric structure in an E. coli wecA2 strain 21548
indicates that wecA is required for synthesis of H. influen-
zae-E. coli LPS chimeric structure. It appears that the Glc-
NAc not only accepts the chimeric H. influenzae structure but
is incorporated into the final chimeric structure. Our studies
have shown that lsgG is also necessary for the formation of
the chimeric structures since if it is absent from the plasmid
constructs with all other genes of the lsg cluster, the chimeric
LPS is not formed (16). LsgG has been shown to be a regu-
latory gene in the modABCD operon and has high homology
to modE, the gene which regulates this operon (35) (Table
VII). It is interesting to speculate that lsgG may be also
involved in the regulation of wecA, enhancing the efficiency of
the chimeric LPS formation. We are currently performing
studies to test this hypothesis.
The second step in the biosynthesis of the chimeric LPS is
the addition of galactose to the 3-position of the terminal Glc-
NAc. The resulting disaccharide, Gal133GlcNAc13, is the
structural moiety observed in pGEMLOS-7, which arises when
the transforming plasmid contains lsgF and lsgG from Hae-
mophilus. Examination of the predicted amino acid sequence of
LsgF indicates that it has high homology to a galactosyltrans-
ferase (AmsD) from Erwinia amylovora (36), suggesting that
lsgF may encode a galactosyltransferase in Haemophilus,
which evidently is capable of recognizing GlcNAc on the pyro-
TABLE V
Monosaccharide compositions of the dephosphorylated oligosaccharide fractions
Molar ratios were derived from comparison to the hydrolysate of the S. typhimurium Ra oligosaccharide of known composition, and then those
values were normalized to either 3.0 or 4.0 heptoses in each fraction.
pGEM
(fraction 2)
pGEM
(fraction 1) pGEMLOS-7 pGEMLOS-5
pGEMLOS-4
(fraction 2)
pGEMLOS-4
(fraction 1)
GlcN 1.0 2.7 2.4 3.3
Gal 0.9 1.1 1.7 3.0 2.8 3.1
Glc 2.2 3.2 3.2 3.4 3.4 3.4
Hep 3.0 4.0 4.0 4.0 4.0 4.0
TABLE VI
Methylation analysis of the dephosphorylated oligosaccharide fractions
Peak areas were measured from the GC/MS EI total ion chromatograms, and values were normalized to the 1,3,6-Glc residue. The data for
pGEMLOS-7 are the average of two runs.
pGEM
(fraction 2)
pGEM
(fraction 1) pGEMLOS-7 pGEMLOS-5
pGEMLOS-4
(fraction 2)
pGEMLOS-4
(fraction 1)
T-Glc 0.5 0.2
T-Gal 0.6 0.5 1.2 0.9 0.7 0.7
1,2-Glc 0.2 0.7 1.0 0.8 0.8 0.7
1,3-Gal 0.4 0.5 0.6
1,6-Glc 0.4 1.1 1.6 1.5 1.3 1.3
1,6-Gal 0.3 0.6
1,3,6-Glc 1.0 1.0 1.0 1.0 1.0 1.0
T-Hep 0.3 0.6 0.6 0.3 0.3 0.2
1,3-Hep 0.3 0.3 0.3 0.4 0.6 0.4
1,7-Hep 0.4 0.6 0.5 0.6
1,3,7-Hep 0.4 0.4 0.2 0.3 0.5 0.5
T-GlcNAc 0.1 0.2 0.2 0.3
1,4-GlcNAc 0.9 1.1 1.0
1,3-GlcNAc 0.3 0.7 0.7 1.0
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phosporyl-undecaprenol carrier lipid as a substrate. Although
unmodified E. coli core LPS structures remain in all of the
chimeric LPS mixtures, the lack of intermediate chimeric
structures as one progresses from pGEMLOS-7 to pGEMLOS-5
and pGEMLOS-4 suggest that once galactose is added to the
GlcNAc-undecaprenyl phosphate, the addition of the other
Haemophilus-related sugars proceeds to defined end points.
Therefore, the nonstoichiometric glycosylation of the E. coli
core LPS by the Haemophilus oligosaccharides may be a func-
tion of the efficiency of the ligase that transfers O-antigen to
the LPS core. This would be analogous to Enterobacteria O-
antigen biosynthesis where one also observes a significant pop-
ulation of unmodified core LPS.
In the pGEMLOS-5 strain, an additional three genes
are contained in the transforming plasmid (lsgC-lsgG), and an
additional GlcNAc and Gal are observed in the resulting
LPS. These sugars now define the tetrasaccharide
Gal134GlcNAc133Gal133GlcNAc13. The LPS from this
transformant is now reactive to the 3F11 mAb, suggesting that
this new disaccharide is b-linked to form the terminal trisac-
charide, Galb134GlcNAcb133Gal13. All of the new lsg genes
contained in this plasmid have some homology with known
glycosyltransferase genes as follows: lsgC has homology with
the amsD from E. amylovora, which encodes a galactosyltrans-
ferase (36), and trsD from Yersinia enterocolitica, a gene in-
volved in LPS inner core synthesis (37); lsgD has homology
with lgtE from Neisseria gonorrhoeae (38) and lgtB from N.
gonorrhoeae and Neisseria meningitidis (39); and lsgE has ho-
mology with a putative glycosyltransferase gene from Acti-
nobacillus sp. (40), the galactosyltransferase gene amsB from
E. amylovora (36), and the glycosyltransferase gene lgtD from
Rickettsia prowazekii (41). The fact that these three additional
lsg genes in the transforming plasmid apparently result in the
addition of only two more sugars to the growing oligosaccharide
chain may indicate that the acceptor for one of the glycosyl-
transferases is absent in the chimeric LPS.
When two more lsg genes are added in the transforming
FIG. 6. MS/MS spectra of the dephosphorylated oligosaccharides from pGEM (A) and pGEMLOS-5 (B). The doubly charged parent ions
are indicated with boxes. Peaks marked with asterisks are believed to be internal fragments, arising from multiple bond cleavages.
FIG. 7. Proposed structures of the chimeric oligosaccharides.
Only the complete E. coli K-12 core structure containing a fourth
heptose on the terminus of the oligosaccharide branch undergoes mod-
ification. Additional saccharides (designated R) are added to the 7-po-
sition of this heptose to form the chimeric oligosaccharides.
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plasmid (lsgA-lsgG) to form the pGEMLOS-4 chimeric strain,
we observe that the 3F11 epitope disappears, and the terminal
Gal residue of the epitope is capped by either a second Gal or a
GlcNAc moiety, apparently linked to the 6-position of the Gal.
These new species present in the pGEMLOS-4 LPS population
were also observed to contain a third Kdo moiety, presumably
somewhere in their core regions. Whereas some of the incom-
plete core structures found in the wild-type E. coli K-12 LPS
populations also contain a third Kdo, of the chimeric struc-
tures, only the structures unique to pGEMLOS-4 were found to
contain a third Kdo. This chimeric strain was also recognized
by mAb 6E4 which recognizes an inner core, Kdo-related
epitope in H. influenzae, suggesting that this third Kdo forms a
different epitope than the one found in the core structure of the
wild-type E. coli LPS. Thus, the addition of lsgA and lsgB to the
transforming plasmid which formed strain pGEMLOS-4 seems
to have multiple effects on the chimeric LPS structure. lsgB is
homologous to the sialyltransferase gene from N. meningitidis
(42). lsgA is homologous to both the wzx gene product from E.
coli (43) and TrsA of Y. enterocolitica (44). These are putative
O-antigen transporters, suggesting that lsgA may encode a
flippase.
Whereas sialyl-N-acetyllactosamine-containing structures
are only minor components of the wild-type H. influenzae type
b strain A2 LOS population (5), we have previously seen that
lsg genes are involved in the synthesis of this epitope. Trans-
poson mutagenesis of lsgD produced mutant strain 281.25,
which lost all ability to add galactose to Hib LOS glycoforms
(6). This strain could not make any of the wild-type LOS struc-
tures larger than the major species containing four glucoses
and three heptoses. Mutation of lsgE (which is downstream of
lsgD) produced strain 276.4 which had essentially the same
defect, except for one important difference, strain 276.4 re-
tained the ability to make the sialyl-N-acetyllactosamine
epitope. These results suggest that in the transposon mutants,
the knockout of lsgD has a polar effect on lsgE, which would
imply that the gene product of lsgE is a galactosyltransferase
required for synthesis of the higher molecular weight wild-type
structures containing terminal galactose(s) on their glucose
disaccharide branches, and the gene product of lsgD is likely an
N-acetylglucosaminyltransferase required for the synthesis of
the sialyl-N-acetyllactosamine epitope (see Table VII). The case
for these assignments can be made on the basis of the homol-
ogies noted above (lsgE is homologous to a galactosyltrans-
ferase gene from E. amylovora) and the LOS glycoforms ob-
served in the 276.4 and 281.25 mutant strains. Since no
TABLE VII
Gene homology
Lsg Homologous genes/proteins Ref. Proteinhomology Protein function
Proposed function(s) of Haemophilus gene
product
LsgA Wzx from E. coli 43 22% identity
44% positive
Putative O-antigen
transporter
Flippase?a
TrsA from Y. enterocolitica 44 24% identity
44% positive
Putative O-antigen
transporter
Wzx from Bacteriodes
fragilis
49 20% identity
36% positive
Putative O-antigen flippase
LsgB Sialyltransferase gene
from N. meningitidis
42 27% identity
46% positive
a-2,3-Sialyltransferase Sialyltransferase or other
glycosyltransferaseb
LsgC AmsD from E. amylovora 36 26% identity
47% positive
Galactosyltransferase 1,4-Galactosyltransferase
TrsD from Y. enterocolitica 37 38% identity
52% positive
Involved in LPS inner core
synthesis
LsgD LgtE from N. gonorrhoeae 38 22% identity
40% positive
Lacto-N-neotetraose
glycosyltransferase
1,3-N-Acetylglucosaminyltransferasec
LgtB from N. gonorrhoeae
and N. meningitidis
39 24% identity
41% positive
Lacto-N-neotetraose
glycosyltransferase
LsgE Putative
glycosyltransferase gene
from Actinobacillus sp.
40 77% identity
84% positive
Putative
glycosyltransferase
Galactosyltransferased
AmsB from E. amylovora 36 27% identity
49% positive
Galactosyltransferase
LgtD from R. prowazekii 41 23% identity
47% positive
Glycosyltransferase
LsgF AmsD from E. amylovora 36 45% identity
66% positive
Galactosyltransferase 1,3-Galactosyltransferase
Putative deoxy-L-talan
synthesis gene from
Actinobacillus sp.
50 83% identity
90% positive
Glycosyltransferase
GDP-mannose biosynthesis
gene from E. coli
51 37% identity
54% positive
Glycosyltransferase
LsgG ModE from E. coli 35 47% identity
64% positive
Molybdenum transport and
regulation of
transcription
Regulation or modulation of the E. coli
wecA gene, which results in the addition
of GlcNAc to the branch heptose
MopB from Rhodobacter
capsulatus
52 32% identity
51% positive
Molybdenum-pterin-
binding protein
a When lsgA and lsgB are both present, the pGEMLOS-5 tetrasaccharide structure can be extended with either a 6-linked galactose or GlcNAc
to form the structures seen in pGEMLOS-4 LPS, which also contain a third Kdo moiety which may be the epitope recognized by mAb 6E4. Thus,
the functions of these two Haemophilus ORFs remain unclear.
b Recent studies with a double gene knockout of lst, a gene with high homology to the sialyltransferase in Haemophilus ducreyi (53), and lsgB
suggest that lsgB may also encode a sialyltransferase.
c The structure of the pGEMLOS-5 LPS suggests that one of the three ORFs C, D, or E encodes a 1,3-N-acetylglucosaminyltransferase and
another encodes a 1,4-galactosyltransferase. Based on our previous investigations of the LOS formed when lsgD or lsgE are knocked out in mutant
strains 281.25 and 276.4, respectively (6), we can conclude that lsgD is likely to encode a 1,3-N-acetylglucosaminlyltransferase and lsgC and lsgE
are both likely to encode galactosyltransferases.
d The LOS formed when lsgE is knocked out (6) suggest that lsgE encodes a galactosyltransferase whose acceptor may be absent in the chimeric
LPS.
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truncated versions of the sialyl-N-acetyllactosamine structure
were seen in the 276.4 LOS population (i.e. no species lacking
either sialic acid or sialic acid plus galactose), lsgD may encode
the glycosyltransferase which adds the GlcNAc to the oligosac-
charide branch. This is also consistent with the observation
that one of the genes in lsgC-lsgE is apparently responsible for
adding GlcNAc to the 3-position of the Gal which is terminal in
the pGEMLOS-7 LPS structure.
CONCLUSIONS
In this study, we have transfected a strain of E. coli that
normally synthesizes a rough LPS with a plasmid containing a
variable set of exogenous genes known to be involved in the
synthesis of carbohydrate epitopes specific to H. influenzae
(16). The resulting chimeric LPS have been shown to contain
additional sugars that have been previously identified as ter-
minal components of native H. influenzae lipooligosaccharides
(5). This chimeric carbohydrate expression system has pro-
vided information that is relevant to unraveling the functions
of these lsg genes and has the additional advantage of being
carried out in the absence of the normal endogenous genetic
background on H. influenzae. Indeed, while gene knockouts of
some of the lsg genes in H. influenzae have been completed (6),
downstream or regulatory gene effects can often complicate
their functional analysis. In this E. coli expression system,
structural analysis of the resulting chimeric LPS has shown
that synthesis proceeded as a serial (non-parallel) synthesis,
that is the new elements of the chimeric LPS were added after
the formation of the E. coli r-LPS. The fact that this synthesis
was sequential (rather than interdigitated with the r-LPS syn-
thesis, for example) allowed for the functions of these H. influ-
enzae gene products to be more readily delineated from the
chimeric oligosaccharide structures. Moreover, screening of the
chimeric LPS products with monoclonal antibodies such as
3F11 enabled us to follow the formation of terminal sugar
sequences (epitopes) that are unique to the Haemophilus strain
from which the plasmid DNA originated.
In addition to its use in unraveling carbohydrate-specific
gene functions, this methodology has potential as a general
method for the production of specific oligosaccharides or as a
method for the production of carbohydrate-based vaccine com-
ponents. For example, the high (and commercially viable) out-
put of LPS biosynthesis in E. coli coupled with its transforma-
tion with exogenous oligosaccharide-specific biosynthesis genes
could prove to be a relatively inexpensive and high throughput
approach for the synthesis of large amounts of complex carbo-
hydrates. Indeed, our largest chimera contained a novel pen-
tasaccharide attached to the host E. coli r-LPS acceptor, al-
though one could easily imagine further extensions to even
larger and more complex structures. One particularly exciting
application of this methodology might be in the construction of
carbohydrate-based vaccines, where carbohydrate epitopes
from pathogenic bacteria could be incorporated into non-lethal
strains. Likewise, the resulting chimeric LPS could be made to
be non-toxic as well, such as through modification of the lipid A
moiety through gene manipulation (45, 46), yielding novel non-
toxic LPS bearing specific epitopes.
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